Article
Igf1r as a therapeutic target in a mouse model of basal-like breast cancer
27 Jan 2009
Abstract excerpt
Considering the strong association between dysregulated insulin-like growth factor (IGF) signaling and various human cancers, we have used an expedient combination of genetic analysis and pharmacological treatment to evaluate the potential of the type 1 IGF receptor (Igf1r) for targeted anticancer therapy in a mouse model of mammary tumorigenesis. In this particular strain of genetically modified animals,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
